References for Dina C. Lev, M.D.

 
YEAR
ARTICLE AUTHORS LINK
2009
 Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the surveillance, epidemiology, and end results registry. Cancer, 115(13), 2971-2979.  Blazer III, D. G., Lazar, A. J., Xing, Y., Askew, R. L., Feig, B. W., Pisters, P. W. T., et al.   
2009
 Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Annals of Surgery, 249(6), 1014-1022.  Zou, C., Smith, K. D., Liu, J., Lahat, G., Myers, S., Wang, W. -., et al.   
2009
 Combining PCI-24781, a novel histone deacetylase inhibitor, with chemotherapy for the treatment of soft tissue sarcoma. Clinical Cancer Research, 15(10), 3472-3483.  Lopez, G., Liu, J., Ren, W., Wei, W., Wang, S., Lahat, G., et al.   
2009
 Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Annals of Surgical Oncology, 16(9), 2579-2586.  Lahat, G., Dhuka, A. R., Lahat, S., Lazar, A. J., Lewis, V. O., Lin, P. P., et al.   
2009
 Computed tomography scan-driven selection of treatment for retroperitoneal liposarcoma histologic subtypes. Cancer, 115(5), 1081-1090.  Lahat, G., Madewell, J. E., Anaya, D. A., Qiao, W., Tuvin, D., Benjamin, R. S., et al.   
2009
 Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: A series of 5 cases with molecular analysis. American Journal of Dermatopathology, 31(3), 297-300.  Wang, W. -., Hornick, J. L., Mallipeddi, R., Zelger, B. G., Rother, J. D., Yang, D., et al.   
2009
 Desmoid tumor: From surgical extirpation to molecular dissection. Current Opinion in Oncology, 21(4), 352-359.  Lazar, A. J. F., Hajibashi, S., & Lev, D. 
2009
 Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Modern Pathology, 22(9), 1201-1209.  Wang, W. -., Mayordomo, E., Zhang, W., Hernandez, V. S., Tuvin, D., Garcia, L., et al.   
2009
 Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor. Molecular Cancer Therapeutics, 8(5), 1157-1168.  Zou, C. Y., Smith, K. D., Zhu, Q. -., Liu, J., McCutcheon, I. E., Slopis, J. M., et al.   
2009
 Establishing prognosis in retroperitoneal sarcoma: A new histology-based paradigm. Annals of Surgical Oncology, 16(3), 667-675.  Anaya, D. A., Lahat, G., Wang, X., Xiao, L., Tuvin, D., Pisters, P. W., et al.   
2009
 Genetic aberrations in soft tissue leiomyosarcoma. Cancer Letters, 275(1), 1-8.  Yang, J., Du, X., Chen, K., Ylipää, A., Lazar, A. J. F., Trent, J., et al.   
2009
 IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Research, 69(3), 1080-1088.  Yang, D., Wang, S., Brooks, C., Dong, Z., Schoenlein, P. V., Kumar, V., et al.   
2009
 Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas. Clinical Cancer Research, 15(8), 2637-2646.  Lahat, G., Lazar, A., Wang, X., Wang, W. -., Zhu, Q. -., Hunt, K. K., et al.   
2009
 Inhibiting platelet-derived growth factor ? reduces ewing's sarcoma growth and metastasis in a novel orthotopic human xenograft model. In Vivo, 23(6), 903-909.  Wang, Y. X., Mandal, D., Wang, S., Hughes, D., Pollock, R. E., Lev, D., et al.   
2009
 Multifocality in retroperitoneal sarcoma: A prognostic factor critical to surgical decision-making. Annals of Surgery, 249(1), 137-142.  Anaya, D. A., Lahat, G., Liu, J., Xing, Y., Cormier, J. N., Pisters, P. W., et al.   
2009
 Outcome of locally recurrent and metastatic angiosarcoma. Annals of Surgical Oncology, 16(9), 2502-2509.  Lahat, G., Dhuka, A. R., Lahat, S., Smith, K. D., Pollock, R. E., Hunt, K. K., et al.   
2009
 Validation of potential therapeutic targets in alveolar soft part sarcoma: An immunohistochemical study utilizing tissue microarray. Histopathology, 55(6), 750-755.  Lazar, A. J., Lahat, G., Myers, S. E., Smith, K. D., Zou, C., Wang, W. -., et al. 
2008
 A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging. Proceedings of the National Academy of Sciences of the United States of America, 105(11), 4471-4476.  Hajitou, A., Lev, D. C., Hannay, J. A. F., Korchin, B., Staquicini, F. I., Soghomonyan, S., et al.   
2008
 Combined vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft tissue sarcoma. Clinical Cancer Research, 14(17), 5466-5475.  Ren, W., Korchin, B., Lahat, G., Wei, C., Bolshakov, S., Nguyen, T., et al.   
2008
 Desmoid tumor: A disease opportune for molecular insights. Histology and Histopathology, 23(1-3), 117-126.  Kotiligam, D., Lazar, A. J. F., Pollock, R. E., & Lev, D. 
2008
 Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo. Clinical Cancer Research, 14(9), 2785-2795.  Ren, W., Korchin, B., Zhu, Q. -., Wei, C., Dicker, A., Heymach, J., et al.   
2008
 Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Modern Pathology, 21(11), 1303-1310.  Wang, W. -., Mayordomo, E., Czerniak, B. A., Abruzzo, L. V., Cin, P. D., Araujo, D. M., et al.   
2008
 Midkine enhances soft-tissue sarcoma growth: A possible novel therapeutictarget. Clinical Cancer Research, 14(16), 5033-5042.  Jin, Z., Lahat, G., Korchin, B., Nguyen, T., Zhu, Q. -., Wang, X., et al.   
2008
 New perspectives for staging and prognosis in soft tissue sarcoma. Annals of Surgical Oncology, 15(10), 2739-2748.  Lahat, G., Tuvin, D., Wei, C., Anaya, D. A., Bekele, B. N., Lazar, A. J., et al.   
2008
 Resectable well-differentiated versus dedifferentiated liposarcomas: Two different diseases possibly requiring different treatment approaches. Annals of Surgical Oncology, 15(6), 1585-1593.  Lahat, G., Anaya, D. A., Wang, X., Tuvin, D., Lev, D., & Pollock, R. E.   
2008
 Sarcoma epidemiology and etiology: Potential environmental and genetic factors. Surgical Clinics of North America, 88(3), 451-481.  Lahat, G., Lazar, A., & Lev, D.   
2008
 Soft tissue sarcoma cells are highly sensitive to AKT blockade: A role for p53-independent up-regulation of GADD45?. Cancer Research, 68(8), 2895-2903.  Zhu, Q. -., Ren, W., Korchin, B., Lahat, G., Dicker, A., Lu, Y., et al.   
2008
 Specific mutations in the ?-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. American Journal of Pathology, 173(5), 1518-1527.  Lazar, A. J. F., Tuvin, D., Hajibashi, S., Habeeb, S., Bolshakov, S., Mayordomo-Aranda, E., et al.   
2008
 The role of surgical margin status in retroperitoneal sarcoma. Journal of Surgical Oncology, 98(8), 607-610.  Anaya, D. A., Lev, D. C., & Pollock, R. E.   
2008
 Tumor immunotherapy in melanoma: Strategies for overcoming mechanisms of resistance and escape. American Journal of Clinical Dermatology, 9(5), 307-311.  Zigler, M., Villares, G. J., Lev, D. C., Melnikova, V. O., & Bar-Eli, M.   
2007
 ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis. Cancer Research, 67(11), 5258-5266.  Schwartz, B., Shoseyov, O., Melnikova, V. O., McCarty, M., Leslie, M., Roiz, L., et al.   
2007
 Angiogenesis-promoting gene patterns in alveolar soft part sarcoma. Clinical Cancer Research, 13(24), 7314-7321.  Lazar, A. J. F., Das, P., Tuvin, D., Korchin, B., Zhu, Q., Jin, Z., et al.   
2007
 High prevalence of p53 exon 4 mutations in soft tissue sarcoma. Cancer, 109(11), 2323-2333.  Das, P., Kotilingam, D., Korchin, B., Liu, J., Yu, D., Lazar, A. J., et al.   
2007
 IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of fas expression. Journal of Immunology, 179(7), 4775-4782.  Yang, D., Thangaraju, M., Browning, D. D., Dong, Z., Korchin, B., Lev, D. C., et al.   
2007
 Isolated limb perfusion: A novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma. Gene Therapy, 14(8), 671-681.  Hannay, J., Davis, J. J., Yu, D., Liu, J., Fang, B., Pollock, R. E., et al.   
2007
 Optimizing treatment of desmoid tumors. Journal of Clinical Oncology, 25(13), 1785-1791.  Lev, D., Kotilingam, D., Wei, C., Ballo, M. T., Zagars, G. K., Pisters, P. W. T., et al. 
2007
 Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: A role for p53/activator protein 2 transcriptional regulation. Molecular Cancer Therapeutics, 6(5), 1650-1660.  Hannay, J. A. F., Liu, J., Zhu, Q. -., Bolshakov, S. V., Li, L., Pisters, P. W. T., et al.   
2006
 Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. Journal of Biological Chemistry, 281(5), 2911-2922.  Melnikova, V. O., Mourad-Zeidan, A. A., Lev, D. C., & Bar-Eli, M.   
2006
 Staging soft tissue sarcoma: Evolution and change. Ca-A Cancer Journal for Clinicians, 56(5), 282-291.  Kotilingam, D., Lev, D. C., Lazar, A. J. F., & Pollock, R. E.   
2006
 Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: Implications for tumor growth, metastasis, and chemoresistance. Cancer Research, 66(17), 8770-8778.  Zhang, L., Hannay, J. A. F., Liu, J., Das, P., Zhan, M., Nguyen, T., et al.   
2006
 Wild-type p53 inhibits nuclear factor-?-induced matrix metalloproteinase-9 promoter activation: Implications for soft tissue sarcoma growth and metastasis. Molecular Cancer Research, 4(11), 803-810.  Liu, J., Zhan, M., Hannay, J. A. F., Das, P., Bolshakov, S. V., Kotilingam, D., et al.   
2005
 Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. Clinical Cancer Research, 11(1), 306-314.  Lev, D. C., Sun, J. K., Onn, A., Stone, V., Nam, D. -., Yazici, S., et al.   
2005
 Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: An animal study. Journal of Surgical Oncology, 89(1), 18-22.  Makrin, V., Lev-Chelouche, D., Even Sapir, E., Paran, H., Rabau, M., & Gutman, M.   
2005
 Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Cancer Research, 65(13), 5578-5587.  Kluger, H. M., Lev, D. C., Kluger, Y., McCarthy, M. M., Kiriakova, G., Camp, R. L., et al.   
2004
 ?B-crystallin as a marker of lymph node involvement in breast carcinoma. Cancer, 100(12), 2543-2548.  Chelouche-Lev, D., Kluger, H. M., Berger, A. J., Rimm, D. L., & Price, J. E.   
2004
 Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: Implications for therapy. European Journal of Cancer, 40(16), 2509-2518.  Chelouche-Lev, D., Miller, C. P., Tellez, C., Ruiz, M., Bar-Eli, M., & Price, J. E.   
2004
 Dual blockade of EGFR and ERK1/2 phosphorylation potentiates growth inhibition of breast cancer cells. British Journal of Cancer, 91(4), 795-802.  Lev, D. C., Kim, L. S., Melnikova, V., Ruiz, M., Ananthaswamy, H. N., & Price, J. E.   
2004
 Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo. Journal of Clinical Oncology, 22(11), 2092-2100.  Lev, D. C., Onn, A., Melinkova, V. O., Miller, C., Stone, V., Ruiz, M., et al.   
2004
 Is photodecomposition more important than metabolic activation for the antitumor activity of dacarbazine (multiple letters). Molecular Cancer Therapeutics, 3(3), 383-384.  Tentori, L., Graziani, G., Chelouche Lev, D., & Bar-Eli, M.   
2004
 Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clinical and Experimental Metastasis, 21(2), 107-118.  Lee, S. K., Huang, S., Lu, W., Lev, D. C., & Price, J. E.   
2003
 A fully human antimelanoma cellular adhesion Molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clinical Cancer Research, 9(17), 6560-6566.  McGary, E. C., Heimberger, A., Mills, L., Weber, K., Thomas, G. W., Shtivelband, M., et al.   
2003
 Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: A possible escape mechanism from chemotherapy. Molecular Cancer Therapeutics, 2(8), 753-763.  Lev, D. C., Ruiz, M., Mills, L., McGary, E. C., Price, J. E., & Bar-Eli, M.   
2003
 Diagnosis and treatment of breast fibroadenomas by ultrasound-guided vacuum-assisted biopsy. Archives of Surgery, 138(7), 796-800.  Sperber, F., Blank, A., Metser, U., Flusser, G., Klausner, J. M., & Lev-Chelouche, D.   
2003
 Laparoscopic adrenalectomy: Indications, technique, complications and follow-up. Israel Medical Association Journal, 5(2), 101-104.  Lev-Chelouche, D., Sagie, B., Keidar, A., Klausner, J. M., & Szold, A.   
2003
 Paget's disease of the breast. Harefuah, 142(6), 433-437+485.  Lev-Schelouch, D., Sperber, F., Gat, A., Klausner, J., & Gutman, M.   
2003
 Presacral tumors: A practical classification and treatment of a unique and heterogenous group of diseases. Surgery, 133(5), 473-478.  Lev-Chelouche, D., Gutman, M., Goldman, G., Even-Sapir, E., Meller, I., Issakov, J., et al.   
2003
 Selection of more aggressive variants of the GI101a human breast cancer cell line: A model for analyzing the metastatic phenotype of breast cancer. Clinical and Experimental Metastasis, 20(6), 515-523.  Chelouche Lev, D., Kiriakova, G., & Price, J. E.   
2002
 Aggressive resection of retroperitoneal sarcoma is superior to simple excision: An animal study using a novel model for retroperitoneal sarcoma. Journal of Surgical Oncology, 81(3), 144-147.  Tsivian, A., Lev-Chelouche, D., Shtabsky, A., Issakov, J., Sidi, A. A., Gutman, M., et al.   
2002
 Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biology & Therapy, 1(5), 459-465.  McGary, E. C., Lev, D. C., & Bar-Eli, M.   
2002
 Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clinical Cancer Research, 8(11), 3584-3591.  McGary, E. C., Weber, K., Mills, L., Doucet, M., Lewis, V., Lev, D. C., et al.   
2002
 The role of interleukin-8 in the initiation and progression of human cutaneous melanoma. Anticancer Research, 22(6 A), 3395-3398.  Gutman, M., Even-Sapir, E., Merimsky, O., Trejo, L., Klausner, J. M., & Lev-Chelouche, D.   
2002
 Therapeutic intervention with breast cancer metastasis. Critical Reviews in Eukaryotic Gene Expression, 12(2), 137-150.  Chelouche Lev, D., & Price, J. E.   
2001
 Diagnostic laparoscopy--a useful tool in abdominal lymphoma. Harefuah, 140(2), 103-105, 191.  Lev-Chelouche, D., Margal, D., Klausner, J. M., & Szold, A.   
2001
 Hydronephrosis associated with colorectal carcinoma: Treatment and outcome. European Journal of Surgical Oncology, 27(5), 482-486.  Lev-Chelouche, D., Keidar, A., Rub, R., Matzkin, H., & Gutman, M.   
2001
 Is forequarter amputation justified for palliation of intractable cancer symptoms? Oncology, 60(1), 55-59.  Merimsky, O., Kollender, Y., Inbar, M., Lev-Chelouche, D., Gutman, M., Issakov, J., et al.   
2001
 Malignant humoral hypercalcemia associated with angiotropic large B cell lymphoma. Harefuah, 140(3), 204-206, 287.  Knobel, B., Sommer, I., Petchenko, P., Lev, D., & Okon, E.   
2001
 Multiple primary malignancies in association with soft tissue sarcomas. Cancer, 91(7), 1363-1371.  Merimsky, O., Kollender, Y., Issakov, J., Bickels, J., Flusser, G., Gutman, M., et al.   
2000
 Gastrointestinal autonomic nerve (GAN) tumor of the rectum. Journal of Clinical Gastroenterology, 30(4), 438-440.  Lev, D., Kariv, Y., Messer, G. Y., Isakov, J., & Gutman, M.   
2000
 Hyperthermic isolated limb perfusion with tumor necrosis factor-? and melphalan in advanced soft-tissue sarcomas: Histopathological considerations. Annals of Surgical Oncology, 7(2), 155-159.  Issakov, J., Merimsky, O., Gutman, M., Kollender, Y., Lev-Chelouche, D., Abu-Abid, S., et al.   
2000
 Metastases to the retroperitoneum in patients with extremity soft tissue sarcoma: An unusual metastatic pattern. Cancer, 88(2), 364-368.  Lev-Chelouche, D., Nakache, R., Soffer, D., Merimsky, O., Klausner, J. M., & Gutman, M.   
2000
 Transanal endoscopic microsurgery: Experience with 75 rectal neoplasms. Diseases of the Colon and Rectum, 43(5), 662-668.  Lev-Chelouche, D., Margel, D., Goldman, G., & Rabau, M. J.   
1999
 Adriamycin-ifosfamide induction chemotherapy for extremity soft tissue sarcoma: Comparison of two non-randomized protocols. Oncology Reports, 6(4), 913-920.  Merimsky, O., Meller, I., Issakov, J., Kollender, Y., Oron, D., Flusser, G., et al.   
1999
 Gastrointestinal stromal sarcomas. British Journal of Surgery, 86(4), 545-549.  Lev, D., Kariv, Y., Issakov, J., Merhav, H., Berger, E., Merimsky, O., et al.   
1999
 Isolated limb perfusion with high-dose tumor necrosis factor and melphalan for kaposi sarcoma. Archives of Surgery, 134(2), 177-180.  Lev-Chelouche, D., Abu-Abeid, S., Merimsky, O., Isakov, J., Kollander, Y., Meller, I., et al.   
1999
 Isolated limb perfusion with tumour necrosis factor-? and melphalan for unresectable bone sarcomas of the lower extremity. European Journal of Surgical Oncology, 25(5), 509-514.  Bickels, J., Manusama, E. R., Gutman, M., Eggermont, A. M. M., Kollender, Y., Abu-Abid, S., et al.   
1999
 Limb desmoid tumors: A possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Surgery, 126(5), 963-967.  Lev-Chelouche, D., Abu-Abeid, S., Nakache, R., Issakov, J., Kollander, Y., Merimsky, O., et al.   
1999
 Morgagni hernia: Unique presentations in elderly patients. Journal of Clinical Gastroenterology, 28(1), 81-82.  Lev-Chelouche, D., Ravid, A., Michowitz, M., Klausner, J. M., & Kluger, Y.   
1999
 Multifocal soft tissue sarcoma: Limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalan. Journal of Surgical Oncology, 70(3), 185-189.  Lev-Chelouche, D., Abu-Abeid, S., Kollander, Y., Meller, I., Isakov, J., Merimsky, O., et al.   
1999
 Retroperitoneal sarcoma. treatment of 51 patients. Harefuah, 136(8), 589-593, 660.  Lev-Chelouche, D., Abu-Abeid, S., Gutman, M., Kluger, Y., Michovitch, M., Meller, I., et al.   
1999
 Severe heat stroke in an intensive care unit: Course of the disease in the intensive care unit, and early and subsequent treatment results. Harefuah, 137(1-2), 9-13, 88.  Halkin, A., Lev, D., Szold, O., Bidermann, P., Bulocnic, S., Halpern, P., et al.   
1999
 The "wandering spleen" syndrome. Harefuah, 136(5), 366-368, 418.  Ravid, A., Lev, D., Makarin, V., Klausner, Y., Umansky, M., & Kluger, Y.   
1998
 Neurotoxicity of isolated limb perfusion with tumor necrosis factor. Journal of the Neurological Sciences, 158(1), 1-4.  Drory, V. E., Lev, D., Groozman, G. B., Gutmann, M., & Klausner, J. M.   
1998
 Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. relevance to the pathophysiology of septic shock. Journal of Clinical Investigation, 101(3), 650-659.  Aderka, D., Sorkine, P., Abu-Abid, S., Lev, D., Setton, A., Cope, A. P., et al.   
1998
 Synergism of tumor necrosis factor-? and melphalan in systemic and regional administration: Animal study. Invasion and Metastasis, 17(4), 169-175.  Gutman, M., Sofer, D., Lev-Chelouche, D., Merimsky, O., & Klausner, J. M.   
1997
 High dose tumor necrosis factor-? and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer, 79(6), 1129-1137.  Gutman, M., Inbar, M., Lev-Shlush, D., Abu-Abid, S., Mozes, M., Chaitchik, S., et al.   
1996
 Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs. Harefuah, 131(7-8), 227-232, 296, 295.  Abu-Abid, S., Gutman, M., Lev, D., Inbar, M., Chaitchik, S., Sorkine, P., et al.   
1996
 Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer. Cancer, 78(5), 1125-1130.  Gutman, M., Abu-Abid, S., Sorkine, P., Inbar, M., Lev, D., Chen, Z., et al.   
1996
 Retrospective analysis of the benefit of various acute-phase reactants for the diagnosis of acute appendicitis. Digestive Surgery, 13(6), 457-459.  Landau, O., Watemberg, S., Arber, N., Subchi, A. -., Lev, D., Hutba, S., et al.   
1996
 Systemic toxicity of tumor necrosis factor administered via high flow isolated limb perfusion. Regional Cancer Treatment, 9(1), 8-12.  Gutman, M., Lev, D., Abu-Abid, S., Sorkin, P., Inbar, M., & Klausner, J. M.   
1995
 Increase in leukocyte adhesiveness and aggregation with stress: A model of human congestive heart failure. Mount Sinai Journal of Medicine, 62(4), 298-301.  Schapiro, J. M., Arber, L., Lev, D., Weksler, D., Liberman, E., Winder, A., et al.   
1995
 Systemic leakage and side effects of tumor necrosis factor ? administered via isolated limb perfusion can be manipulated by flow rate adjustment. Archives of Surgery, 130(10), 1079-1084.  Sorkin, P., Abu-Abid, S., Lev, D., Gutman, M., Aderka, D., Halpern, P., et al.   
1992
 Intestinal obstruction due to phytobezoar in childhood. Pediatric Surgery International, 7(4), 303-305.  Serour, F., Gorenstein, A., Kaufman, M., & Lev, D.   
 
 

copyright© 2005-2010 Desmoid Tumor Research Foundation | terms of use | privacy policy